Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
about
Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7Vaspin inhibits kallikrein 7 by serpin mechanismSelective cytotoxicity of amidinopiperidine based compounds towards Burkitt's lymphoma cells involves proteasome inhibitionHypomaturation enamel defects in Klk4 knockout/LacZ knockin miceKallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft modelDirect and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics.The biology of ovarian cancer: new opportunities for translationThree dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancyKallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival.Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome.Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Correlation of the expression of human kallikrein-related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma.KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cellsKallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.The role of human tissue kallikreins 7 and 8 in intracranial malignancies.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
P2860
Q24674282-CDC15BF7-680E-4415-A290-0267924C2C95Q27676095-BB7302F7-ECC9-4631-A1C8-34212B0E3BD3Q28481652-119D3C9F-2F78-44E5-9290-258AF92678EBQ28509062-A99AAEFB-A60C-40B6-BFBE-44FC9F8F86BDQ28742738-65CE2E63-D45C-4175-A2A3-DB0569730C17Q30825171-DC7738AB-2E29-4176-BD58-8949E0A1602CQ33622369-90E28E4C-4CA2-4F1D-BCA3-C4ABA30A4866Q33794911-71852586-6BD0-416B-970D-F563EDB648A3Q34056033-743CADE9-A29C-4B7A-94B0-A5D1CF0A44B2Q34205091-BCD98AAB-7A7B-42E2-928D-A66E433EF278Q34738849-3AC542E2-3FDA-4AF7-8154-C5B1A40BAD95Q35837949-BA08BF2E-6188-4510-89CB-752BBF6C4E0CQ36125886-57C2DD93-11D0-4F97-A755-748162EDCAE3Q36595049-05C76E96-49EF-476E-8ADB-D3D37FDFA519Q36627182-B02DAA5F-0FCE-4456-8C4D-EB22E35D7F41Q37228450-5F687CC9-101C-4815-9AC0-4B5A19C60911Q37480184-E716E748-93E3-49A7-AF75-E5886624747FQ37952006-2AA7834F-28EB-40C0-BE75-BE38424B387EQ38415467-E62AB6B0-6192-45C5-B664-DE3192DFD721Q38718409-7BCCED38-1D8B-4815-9489-C2D58B70AED3Q39080408-897E0A3B-0F43-4A10-A285-7FBC51419089Q39113924-FB55A6F0-9585-4416-89FB-F1A601AD16ADQ39961341-8DA8C613-6E29-4CAE-839F-49D0E55A2E3FQ40007756-CF7397BD-2951-4F98-8658-940093A5BA04Q40011698-A505A61A-4D5F-4CBB-811B-57B2BE5DD78CQ40020532-13B47511-41BE-4705-B3FA-5DB98131C088Q42093939-324C11D2-47D0-41EE-A24F-87BC6DBE8568Q43418010-70FB8A00-5BBC-4F50-B0B6-AB8DCB111592Q46588877-C280F7C0-405F-4ADF-B199-E7B17B44E3E4Q48355523-BF55AB32-65FA-4DC5-8179-0346776397F5Q56888917-B5F3DFA3-43DB-4363-BD08-5E54E47F8D1A
P2860
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Overexpression of the human ti ...... otype of ovarian cancer cells.
@en
type
label
Overexpression of the human ti ...... otype of ovarian cancer cells.
@en
prefLabel
Overexpression of the human ti ...... otype of ovarian cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Overexpression of the human ti ...... otype of ovarian cancer cells.
@en
P2093
Achim Krüger
Antoninus Soosaipillai
Leon Holzscheiter
Manfred Schmitt
Matthias J E Arlt
Panagiotis Prezas
Petar Viktorov
Viktor Magdolen
P2860
P304
P356
10.1515/BC.2006.102
P577
2006-06-01T00:00:00Z